Alternatives to YD Pharmaceuticals
YD Pharmaceuticals is a Biotech tool: yD Pharmaceuticals is a Portuguese medical cannabis producer focused on high-quality cultivation and product development. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to YD Pharmaceuticals
- Website
Xinteza API42BiotechSan Francisco, United States$10.0MBiosynthesis of cannabinoids and psychedelics using advanced biotechnology.
- Website
Denali Therapeutics70BiotechSouth San Francisco, United States$1.0BBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
Cradle69BiotechAmsterdam, Netherlands$102.4MCradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
- Website
BenchSci64BiotechToronto, Canada$197.3MAI-powered platform for understanding disease biology and accelerating drug discovery.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
BioSymetrics63BiotechBoston, United States$6.6MPhenomics-driven AI company translating disease biology into precision medicine discoveries.
- Website
Manifold Bio63BiotechBoston, United States$118.0MAI-guided drug discovery platform for tissue-targeted medicines.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Synthace62BiotechLondon, United Kingdom$60.6MSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
- Website
Deep Genomics61BiotechToronto, Canada$241.0MAI-powered biotechnology company developing RNA therapeutics for genetic diseases.
- Website
Iambic Therapeutics61BiotechSan Diego, United States$50.0MAI-driven drug discovery company developing novel medicines for unmet patient needs.
- Website
Arzeda61BiotechSeattle, United States$60.0MComputational protein design company creating novel enzymes and proteins using AI and physics-based modeling.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
LabGenius Therapeutics61BiotechLondon, United Kingdom$3.0MAI-driven drug discovery platform for rapid development of novel therapeutics.
- Website
Moleculent61BiotechStockholm, Sweden$46.0MMapping cell-cell communication at scale in human tissue.
- Website
ImCheck Therapeutics60BiotechMarseille, France$164.0MImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.
- Website
TippingPoint Biosciences59BiotechCambridge, USA$14.5MDeveloping novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Relay Therapeutics58BiotechCambridge, United States$825.0MClinical-stage precision medicine company using protein motion insights for drug discovery.
Showing the 20 closest matches. See the rest on the YD Pharmaceuticals profile.
Compare YD Pharmaceuticals head to head
Side by side on what each one does, what it costs, and what real users report.